Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Midregional Proatrial Natriuretic Peptide (MRproANP) is associated with vertebral fractures and low bone density in patients with chronic obstructive pulmonary disease (COPD)

    Patients with COPD are often affected by loss of bone mineral density (BMD) and osteoporotic fractures. Natriuretic peptides (NP) are known as cardiac markers, but have also been linked to fragility-associated...

    Franziska C. Trudzinski, Rudolf A. Jörres, Peter Alter, Henrik Watz in Respiratory Research (2024)

  2. No Access

    Article

    Geschlechtsspezifische Aspekte bei der chronisch obstruktiven Lungenerkrankung

    In den kommenden Jahren wird die Zahl der Fälle von Patienten und Patientinnen mit chronisch obstruktiver Lungenerkrankung (COPD) weiter ansteigen, wobei der Anstieg bei Frauen und in Regionen mit niedrigen un...

    Prof. Franziska Trudzinski, Konstantina Kontogianni in Zeitschrift für Pneumologie (2024)

  3. Article

    Open Access

    Period of hospitalization and mortality in transferred versus non-transferred COVID-19 patients: results from Germany

    COVID-19 was a challenge for health-care systems worldwide, causing large numbers of hospitalizations and inter-hospital transfers. We studied whether transfer, as well as its reason, was associated with the d...

    Pascal Suski, Rudolf A. Jörres, Sebastian Engelhardt, Kathrin Kahnert in Scientific Reports (2024)

  4. Article

    Open Access

    Effects of triple therapy on disease burden in patients of GOLD groups C and D: results from the observational COPD cohort COSYCONET

    Randomized controlled trials described beneficial effects of inhaled triple therapy (LABA/LAMA/ICS) in patients with chronic obstructive pulmonary disease (COPD) and high risk of exacerbations. We studied whet...

    Jennifer A. Zader, Rudolf A. Jörres, Imke Mayer, Peter Alter in BMC Pulmonary Medicine (2024)

  5. Article

    Open Access

    Tumor seeding following CT- guided transthoracic needle biopsy in lung cancer. A case report

    As a result of advances in the treatment of lung cancer, the life expectancy of lung cancer patients has improved significantly, but it remains the leading cause of cancer death worldwide. For decades, most of...

    Thomas Melzer, Caroline Maria Hackl, Julia Walter, Jürgen Behr in BMC Pulmonary Medicine (2023)

  6. Article

    Open Access

    Gender-specific differences in COPD symptoms and their impact for the diagnosis of cardiac comorbidities

    In chronic obstructive pulmonary disease (COPD), gender-specific differences in the prevalence of symptoms and comorbidity are known.

    Franziska C. Trudzinski, Christina Kellerer in Clinical Research in Cardiology (2023)

  7. Article

    Open Access

    Cardiovascular predictors of mortality and exacerbations in patients with COPD

    In chronic obstructive pulmonary disease (COPD), comorbidities and worse functional status predict worse outcomes, but how these predictors compare with regard to different outcomes is not well studied. We thu...

    Peter Alter, Tanja Lucke, Henrik Watz, Stefan Andreas in Scientific Reports (2022)

  8. Article

    A simple risk score for mortality including the PCR Ct value upon admission in patients hospitalized due to COVID-19

    To develop a simple score for the outcomes from COVID-19 that integrates information obtained at the time of admission including the Ct value (cycle threshold) for SARS-CoV-2.

    Luis Kurzeder, Rudolf A. Jörres, Thomas Unterweger, Julian Essmann in Infection (2022)

  9. Article

    Open Access

    Sex-specific associations of comorbidome and pulmorbidome with mortality in chronic obstructive pulmonary disease: results from COSYCONET

    In patients with COPD, it has not been comprehensively assessed whether the predictive value of comorbidities for mortality differs between men and women. We therefore aimed to examine sex differences of COPD ...

    Franziska C. Trudzinski, Rudolf A. Jörres, Peter Alter, Julia Walter in Scientific Reports (2022)

  10. Article

    Open Access

    Consequences of the COVID-19 pandemic on lung cancer care and patient health in a German lung cancer center: results from a cross-sectional questionnaire

    The novel coronavirus SARS-CoV-2 has caused a global COVID-19 pandemic, leading to worldwide changes in public health measures. In addition to changes in the public sector (lockdowns, contact restrictions), ho...

    Julia Walter, Laura Sellmer, Kathrin Kahnert, Rosemarie Kiefl in Respiratory Research (2022)

  11. Article

    Open Access

    Reduced decline of lung diffusing capacity in COPD patients with diabetes and metformin treatment

    We studied whether in patients with COPD the use of metformin for diabetes treatment was linked to a pattern of lung function decline consistent with the hypothesis of anti-aging effects of metformin. Patients...

    Kathrin Kahnert, Stefan Andreas, Christina Kellerer in Scientific Reports (2022)

  12. Article

    Open Access

    Prediction of lung emphysema in COPD by spirometry and clinical symptoms: results from COSYCONET

    Lung emphysema is an important phenotype of chronic obstructive pulmonary disease (COPD), and CT scanning is strongly recommended to establish the diagnosis. This study aimed to identify criteria by which phys...

    Christina Kellerer, Rudolf A. Jörres, Antonius Schneider in Respiratory Research (2021)

  13. Article

    Open Access

    Correction to: Treatment Sequencing for Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung Cancer

    A correction to this paper has been published: https://doi.org/10.1007/s40265-021-01536-8

    Diego Kauffmann-Guerrero, Kathrin Kahnert, Rudolf M. Huber in Drugs (2021)

  14. Article

    Open Access

    Systemic inflammation and pro-inflammatory cytokine profile predict response to checkpoint inhibitor treatment in NSCLC: a prospective study

    Treatment with single agent immune checkpoint inhibitors (ICIs) has tremendously changed second line therapy in NSCLC. However, there are still no reliable biomarkers predicting response and survival in this g...

    Diego Kauffmann-Guerrero, Kathrin Kahnert, Rosemarie Kiefl in Scientific Reports (2021)

  15. Article

    Open Access

    Treatment Sequencing for Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung Cancer

    Non-small-cell lung cancer (NSCLC) accounts for about 85% of all lung cancer cases and is the leading cause of cancer-related deaths. Most NSCLC patients are diagnosed with advanced disease and require systemi...

    Diego Kauffmann-Guerrero, Kathrin Kahnert, Rudolf M. Huber in Drugs (2021)

  16. Article

    Open Access

    Health-related quality of life associates with change in FEV1 in COPD: results from the COSYCONET cohort

    Forced expiratory volume in one second (FEV1) characterizes the pathophysiology of COPD and different trajectories of FEV1 decline have been observed in patients with COPD (e.g. gradual or episodic). There is lim...

    Johanna I. Lutter, Rudolf A. Jörres, Kathrin Kahnert in BMC Pulmonary Medicine (2020)

  17. No Access

    Living Reference Work Entry In depth

    Endoskopische Diagnostik bei thorakalen Tumoren

    Basierend auf den Empfehlungen der S3-Leitlinie zur Behandlung des Lungenkarzinoms beinhaltet die Basisdiagnostik bei klinischem oder radiologischem Verdacht auf ein Lungenkarzinom neben Anamnese, klinischen u...

    Kathrin Kahnert, Amanda Tufman, Jeremias Götschke in Kompendium Internistische Onkologie

  18. Article

    Open Access

    The association of cognitive functioning as measured by the DemTect with functional and clinical characteristics of COPD: results from the COSYCONET cohort

    Alterations of cognitive functions have been described in COPD. Our study aimed to disentangle the relationship between the degree of cognitive function and COPD characteristics including quality of life (QoL).

    Sarah Marietta von Siemens, Robert Perneczky, Claus F. Vogelmeier in Respiratory Research (2019)

  19. No Access

    Article

    Response assessment in non-small cell lung cancer immunotherapy: initial experiences in utilizing FDG PET/CT and the PD-1 blocker nivolumab

    Most Non-Small-Cell lung cancer (NSCLC) patients need systemic treatment. Immunotherapy is now current standard in first- and second-line treatment. In all pivotal studies, staging was performed using conventi...

    Diego Kauffmann-Guerrero, Andreas Schindler in memo - Magazine of European Medical Oncolo… (2019)

  20. Article

    Open Access

    Effects of airway obstruction and hyperinflation on electrocardiographic axes in COPD

    COPD influences cardiac function and morphology. Changes of the electrical heart axes have been largely attributed to a supposed increased right heart load in the past, whereas a potential involvement of the l...

    Peter Alter, Henrik Watz, Kathrin Kahnert, Klaus F. Rabe in Respiratory Research (2019)

previous disabled Page of 2